https://lipidbank.jp/mediawiki/index.php?action=history&feed=atom&title=LBF20303PG05 LBF20303PG05 - Revision history 2026-04-29T23:20:10Z Revision history for this page on the wiki MediaWiki 1.43.0 https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53343&oldid=prev Editor at 06:39, 8 November 2010 2010-11-08T06:39:29Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 15:39, 8 November 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l11">Line 11:</td> <td colspan="2" class="diff-lineno">Line 11:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=PGD3 has almost same ability to decrease systemic blood pressure in rats and to decrease intraocular pressure in rabbits.[[Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790}}]][[Reference:Goh_Y:Nakajima_M:Azuma_I:Hayaishi_O:,Jpn. J. Ophthalmol.,1988,32,471|{{RelationTable/GetFirstAuthor|Reference:Goh_Y:Nakajima_M:Azuma_I:Hayaishi_O:,Jpn. J. Ophthalmol.,1988,32,471}}]][[Reference:Kulkarni_PS:Srinivasan_BD:,Invest. Ophthalmol. Vis. Sci.,1985,26,1178|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Srinivasan_BD:,Invest. Ophthalmol. Vis. Sci.,1985,26,1178}}]] However, it is 3 to 5 times more potent than PGD2 in the inhibition of ADP-induced human platelet aggregation.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=PGD3 has almost same ability to decrease systemic blood pressure in rats and to decrease intraocular pressure in rabbits.[[Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790}}]][[Reference:Goh_Y:Nakajima_M:Azuma_I:Hayaishi_O:,Jpn. J. Ophthalmol.,1988,32,471|{{RelationTable/GetFirstAuthor|Reference:Goh_Y:Nakajima_M:Azuma_I:Hayaishi_O:,Jpn. J. Ophthalmol.,1988,32,471}}]][[Reference:Kulkarni_PS:Srinivasan_BD:,Invest. Ophthalmol. Vis. Sci.,1985,26,1178|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Srinivasan_BD:,Invest. Ophthalmol. Vis. Sci.,1985,26,1178}}]] However, it is 3 to 5 times more potent than PGD2 in the inhibition of ADP-induced human platelet aggregation.<ins style="font-weight: bold; text-decoration: none;">[[Reference:Herschman_HR:,Biochim._Biophys._Acta,1996,1299,125|{{RelationTable/GetFirstAuthor|Reference:Herschman_HR:,Biochim._Biophys._Acta,1996,1299,125}}]] [[Reference:Smith_WL:Garavito_RM:DeWitt_DL:,J. Biol. Chem.,1996,271,33157|{{RelationTable/GetFirstAuthor|Reference:Smith_WL:Garavito_RM:DeWitt_DL:,J. Biol. Chem.,1996,271,33157}}]]</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr> <!-- diff cache key wikidb:diff:1.41:old-53342:rev-53343:php=table --> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53342&oldid=prev Editor at 08:59, 21 October 2010 2010-10-21T08:59:47Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:59, 21 October 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1705</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1705</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010142</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010142</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(9alpha,15S) -Dihydroxy-11-oxo-prosta- (5-cis<del style="font-weight: bold; text-decoration: none;">,13</del>-<del style="font-weight: bold; text-decoration: none;">trans,</del>17<del style="font-weight: bold; text-decoration: none;">-cis</del>) -trien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(9alpha,15S) -Dihydroxy-11-oxo-prosta- (<ins style="font-weight: bold; text-decoration: none;">cis-</ins>5<ins style="font-weight: bold; text-decoration: none;">,trans</ins>-<ins style="font-weight: bold; text-decoration: none;">13,</ins>cis-17) -trien-1-oic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3&amp;&amp;(9alpha,15S) -Dihydroxy-11-oxo-prosta- (5Z,13E,17Z) -trien-1-oic acid&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3&amp;&amp;(9alpha,15S) -Dihydroxy-11-oxo-prosta- (5Z,13E,17Z) -trien-1-oic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]</div></td></tr> <!-- diff cache key wikidb:diff:1.41:old-53341:rev-53342:php=table --> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53341&oldid=prev Editor at 07:30, 27 May 2010 2010-05-27T07:30:57Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:30, 27 May 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1705</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1705</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010142</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010142</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,15S-Dihydroxy-11-oxo-prosta-<del style="font-weight: bold; text-decoration: none;">5Z</del>,<del style="font-weight: bold; text-decoration: none;">13E</del>,<del style="font-weight: bold; text-decoration: none;">17Z</del>-trien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=<ins style="font-weight: bold; text-decoration: none;">(</ins>9alpha,15S<ins style="font-weight: bold; text-decoration: none;">) </ins>-Dihydroxy-11-oxo-prosta- <ins style="font-weight: bold; text-decoration: none;">(5-cis</ins>,<ins style="font-weight: bold; text-decoration: none;">13-trans</ins>,<ins style="font-weight: bold; text-decoration: none;">17-cis) </ins>-trien-1-oic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3&amp;&amp;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3<ins style="font-weight: bold; text-decoration: none;">&amp;&amp;(9alpha,15S) -Dihydroxy-11-oxo-prosta- (5Z,13E,17Z) -trien-1-oic acid</ins>&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> <!-- diff cache key wikidb:diff:1.41:old-53340:rev-53341:php=table --> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53340&oldid=prev Editor at 05:19, 23 April 2010 2010-04-23T05:19:34Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 14:19, 23 April 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1705</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1705</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010142</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010142</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,15S-<del style="font-weight: bold; text-decoration: none;">dihydroxy</del>-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,15S-<ins style="font-weight: bold; text-decoration: none;">Dihydroxy</ins>-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]</div></td></tr> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53339&oldid=prev Editor at 21:00, 14 April 2010 2010-04-14T21:00:00Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 06:00, 15 April 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td> <td colspan="2" class="diff-lineno">Line 7:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010142</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010142</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3<del style="font-weight: bold; text-decoration: none;">&amp;&amp;9alpha,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid</del>&amp;&amp;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> <!-- diff cache key wikidb:diff:1.41:old-53338:rev-53339:php=table --> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53338&oldid=prev Editor at 10:00, 25 February 2010 2010-02-25T10:00:10Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 19:00, 25 February 2010</td> </tr><tr><td colspan="4" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr> <!-- diff cache key wikidb:diff:1.41:old-53337:rev-53338 --> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53337&oldid=prev Editor at 14:00, 19 February 2010 2010-02-19T14:00:10Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td> </tr><tr><td colspan="4" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr> <!-- diff cache key wikidb:diff:1.41:old-53336:rev-53337 --> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53336&oldid=prev Editor at 14:00, 19 February 2010 2010-02-19T14:00:00Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td> </tr><tr><td colspan="4" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr> <!-- diff cache key wikidb:diff:1.41:old-53335:rev-53336 --> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53335&oldid=prev Editor at 21:00, 6 January 2010 2010-01-06T21:00:00Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 06:00, 7 January 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l11">Line 11:</td> <td colspan="2" class="diff-lineno">Line 11:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">|Biological Activity=PGD3 has almost same ability to decrease systemic blood pressure in rats and to decrease intraocular pressure in rabbits.[[Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Morton_DR:Peterson_DC:Nishizawa_EE:Miller_WL:,J. Med. Chem.,1983,26,790}}]][[Reference:Goh_Y:Nakajima_M:Azuma_I:Hayaishi_O:,Jpn. J. Ophthalmol.,1988,32,471|{{RelationTable/GetFirstAuthor|Reference:Goh_Y:Nakajima_M:Azuma_I:Hayaishi_O:,Jpn. J. Ophthalmol.,1988,32,471}}]][[Reference:Kulkarni_PS:Srinivasan_BD:,Invest. Ophthalmol. Vis. Sci.,1985,26,1178|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Srinivasan_BD:,Invest. Ophthalmol. Vis. Sci.,1985,26,1178}}]] However, it is 3 to 5 times more potent than PGD2 in the inhibition of ADP-induced human platelet aggregation.</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr> <!-- diff cache key wikidb:diff:1.41:old-53334:rev-53335:php=table --> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20303PG05&diff=53334&oldid=prev Editor at 11:55, 25 November 2009 2009-11-25T11:55:00Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 20:55, 25 November 2009</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l8">Line 8:</td> <td colspan="2" class="diff-lineno">Line 8:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3&amp;&amp;9alpha,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;Prostaglandin D_3&amp;&amp;9alpha,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]<del style="font-weight: bold; text-decoration: none;">;&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Source=PGD3 is produced by the metabolism of EPA via the cyclooxygenase pathway.[[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr> <!-- diff cache key wikidb:diff:1.41:old-53333:rev-53334:php=table --> </table> Editor